Cookies on VetMed Resource

Like most websites we use cookies. This is to ensure that we give you the best experience possible.

 

Continuing to use www.cabi.org  means you agree to our use of cookies. If you would like to, you can learn more about the cookies we use.

VetMed Resource

Veterinary information to support practice, based on evidence and continuing education

Sign up to start receiving our Veterinary & Animal Sciences e-newsletter, book alerts and offers direct to your inbox.

Results per page:

Search results

Abstract

Smarter understanding of diabetes pathophysiology and pharmacology of insulin therapy can lead to better clinical outcomes. Rather than looking for an insulin formulation that is considered "best" for a general population, it could be appropriate to seek the "smart" insulin choice, tailored to the...

Author(s)
Gilor, C.; Fleeman, L. M.
Publisher
Wiley, Oxford, UK
Citation
Journal of Small Animal Practice, 2022, 63, 9, pp 645-660
Abstract

The year 2021 marked the centenary of the isolation of a therapeutic form of insulin and its successful use in dogs. This was a landmark moment that subsequently and rapidly led to the commercial manufacture of insulin for use in humans. The impact of insulin was almost miraculous as those destined ...

Author(s)
Shiel, R. E.; Mooney, C. T.
Publisher
BioMed Central Ltd, London, UK
Citation
Canine Medicine and Genetics, 2022, 9, 1, pp (14 February 2022)
AbstractFull Text

Diabetes mellitus (DM) is a metabolic disorder characterized by persistent hyperglycemia. Although most diabetic dogs have type 1 diabetes mellitus, type 2 diabetes mellitus can also especially afflict those who are obese. This study aims to investigate how nutritional management can help in the...

Author(s)
Massari, C. H. de A. L.; Freires, L. R.; Costa, H. L. R.; Oyama, S. M. R.; Saad, F. M. de O. B.
Publisher
Pubvet, Maringá, Brazil
Citation
PUBVET, 2022, 16, 1,
Abstract

Insulin glargine 300 U/mL and insulin detemir are synthetic long-acting insulin analogs associated with minimal day-to-day variability or episodes of hypoglycemia in people. Here, 8 healthy purpose-bred dogs each received 2.4 nmol/kg subcutaneous injections of insulin detemir (0.1 U/kg) and insulin ...

Author(s)
Fink, H.; Herbert, C.; Gilor, C.
Publisher
Elsevier Inc, New York, USA
Citation
Domestic Animal Endocrinology, 2018, 64, pp 17-30
Abstract

Background: Day-to-day variability impacts safety of insulin therapy and the choice of monitoring strategies. Side-by-side comparisons of insulin formulations in diabetic dogs are scarce. Hypothesis/Objectives: Insulin glargine 300 U/mL (IGla300) and insulin degludec (IDeg) are associated with less ...

Author(s)
Miller, M.; Pires, J.; Crakes, K.; Greathouse, R.; Quach, N.; Gilor, C.
Publisher
Wiley, Boston, USA
Citation
Journal of Veterinary Internal Medicine, 2021, 35, 5, pp 2131-2139
Abstract

The same food formulation processed to obtain two different starch gelatinisations (SG) and resistant starch (RS) contents was evaluated in old and adult dogs, regarding apparent total tract digestibility (ATTD) of nutrients, fermentation products in faeces, and postprandial glucose and insulin...

Author(s)
Ribeiro, É. de M.; Peixoto, M. C.; Putarov, T. C.; Monti, M.; Pacheco, P. D. G.; Loureiro, B. A.; Pereira, G. T.; Carciofi, A. C.
Publisher
Taylor & Francis, Abingdon, UK
Citation
Archives of Animal Nutrition, 2019, 73, 6, pp 485-504
Abstract

Background: Anti-insulin antibodies (AIA) occur in diabetic dogs after insulin therapy, although their clinical significance is unclear. Hypothesis: Treatment of diabetic dogs with heterologous insulin is more likely to stimulate production of AIA than is treatment with homologous insulin. Animals: ...

Author(s)
Davison, L. J.; Walding, B.; Herrtage, M. E.; Catchpole, B.
Publisher
Blackwell Publishing, Oxford, UK
Citation
Journal of Veterinary Internal Medicine, 2008, 22, 6, pp 1317-1325
Abstract

Clinical studies that compare lente insulin and neutral protamine Hagedorn (NPH) insulin in diabetic dogs are lacking. This is a prospective, randomised, controlled clinical study aimed to compare the efficacy and safety of lente insulin and NPH insulin in diabetic dogs. Thirty client-owned, newly...

Author(s)
Fracassi, F.; Linari, G.; Baldo, F. del; Cunzolo, A. di; D'Angelo, S.; Malerba, E.; Carotenuto, G.; Bonfanti, U.; Corradini, S.
Publisher
BMJ Publishing Group, London, UK
Citation
Veterinary Record, 2018, 183, 8, pp 262
Abstract

Diabetes mellitus (DM) is a common disease encountered in canine and feline medicine. The 2018 AAHA Diabetes Management Guidelines for Dogs and Cats revise and update earlier guidelines published in 2010. The 2018 guidelines retain much of the information in the earlier guidelines that continues to ...

Author(s)
Behrend, E.; Holford, A.; Lathan, P.; Rucinsky, R.; Schulman, R.
Publisher
American Animal Hospital Association, Denver, USA
Citation
Journal of the American Animal Hospital Association, 2018, 54, 1, pp 1-21
AbstractFull Text

Corneal ulcers in dogs and cats are very common. Regardless of etiology (melting or indolent corneal ulcers) and of the affected layers of the cornea (superficial or deep corneal ulcers), local treatment is performed using eye drops with antibiotic and corneal healing drugs (hyaluronic acid and...

Author(s)
Ionascu, I.; Argãsealã, A.; Uzun, S.; Gîrdan, G.; Gîrloantă, A.; Calentaru, V.
Publisher
University of Agronomic Sciences and Veterinary Medicine of Bucharest, Bucharest, Romania
Citation
AgroLife Scientific Journal, 2020, 9, 1, pp 164-171

Refine Results

Sort Order
Author
Geographical Location
Item Type
Language
Organisms
Subject Topics

Datasheet Filter

Datasheet Type